Effect of Red and Blue Light Irradiation on Postoperative Wound Healing in Perianal Absces

September 1, 2025 updated by: The Affiliated Hospital of Putian University

Effect of Red and Blue Light Irradiation on Postoperative Wound Healing in Perianal Abscess: a Single-center Prospective Open-label Randomized Clinical Trial

This study aims to investigate whether specialized red-blue light irradiation facilitates faster postoperative recovery and reduces complication rates in patients following perianal abscess surgery. A total of 222 eligible patients were randomly allocated equally into three groups (74 per group):①Routine Care Group: Standard wound care including cleansing and dressing changes;②Red Light Therapy Group: Routine care plus red light phototherapy;③Combined Red-Blue Light Therapy Group: Routine care plus concurrent red and blue light phototherapy.Wound healing time and incidence of complications were compared to assess postoperative recovery across interventions. The primary hypothesis posits that adjunctive phototherapy-particularly combined red-blue light irradiation-will significantly enhance wound healing, reduce edema and pain, and decrease complication rates (e.g.bleeding, urinary retention) compared to routine care alone.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

222

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Chenxing C Jian
  • Phone Number: +8613959538950
  • Email: ptyyjcx@126.com

Study Locations

      • Putian, China
        • Affiliated Hospital of Putian University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged between 18 and 75 years;
  • Clinical diagnosis of perianal abscess;
  • Procedure: Radical resection with incision and drainage.

Exclusion Criteria:

  • Concurrent anorectal disorders (hemorrhoids, anal fissure) or malignancies/infectious diseases;
  • History of psychiatric disorders;
  • Analgesic use within 7 days preoperatively;
  • Coagulopathy or cardiac/hepatic dysfunction;
  • Pregnancy or lactation;
  • Contraindications to phototherapy;
  • IBD-related perianal abscess.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
Routine care of patients after surgery for perianal abscesses.
Experimental: Red Ligh Group
Postoperative care of patients with perianal abscesses using routine plus red light irradiation.
Patients in the red light group received red light therapy concurrently with standard care.
Experimental: Combined Red-Blue Light Group
Use of routine plus red and blue light in postoperative care of patients with perianal abscesses.
Patients in the red and blue light group received combined red and blue light therapy concurrently with standard care。

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound healing time
Time Frame: Measurements were taken over a time frame of 24 hours postoperatively to complete epithelialisation.
Defined as 100% re-epithelialization assessed by blinded evaluator.
Measurements were taken over a time frame of 24 hours postoperatively to complete epithelialisation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain intensity
Time Frame: Baseline, Day 1, 3, 5, 7, and Day 14±2
Assessed at rest and during defecation.Numerical Rating Scale will be used,patients are asked to choose a whole number (integer) from 0 to 10 that best describes their pain.0 usually means "no pain."10 means "the worst pain imaginable."
Baseline, Day 1, 3, 5, 7, and Day 14±2
Peripheral tissue edema(Grade 0-3)
Time Frame: Day 1, 3, 5, 7, and Day 14±2
  • Grade 0 (None): No edema.
  • Grade 1 (Mild): Mild edema with slight swelling around the incision; skin folds remain clearly visible.
  • Grade 2 (Moderate): Moderate edema with pronounced swelling around the incision; skin folds are indistinct.
  • Grade 3 (Severe): Severe edema with marked swelling around the incision; skin folds are obliterated.
Day 1, 3, 5, 7, and Day 14±2
Assessment of Granulation Tissue in Wound Bed
Time Frame: Day 1, 3, 5, 7, and Day 14±2
  • Grade 0 (Absent): No granulation tissue present.
  • Grade 1 (Poor): Minimal, pale, and friable granulation tissue with easy bleeding.
  • Grade 2 (Fair): Moderate amount of granulation tissue; pinkish-red in color but remains somewhat friable.
  • Grade 3 (Good): Healthy, abundant granulation tissue filling the wound bed; beefy red in color and firm to the touch, with minimal bleeding.
Day 1, 3, 5, 7, and Day 14±2
Length of hospital stay
Time Frame: From surgery end to discharge (up to 7 days)
Measured in hours with standardized discharge criteria.
From surgery end to discharge (up to 7 days)
Complication incidence
Time Frame: Within 30 days postoperatively
Measurements include the incidence of postoperative bleeding, urinary retention, etc.
Within 30 days postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 15, 2025

Primary Completion (Estimated)

August 14, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

July 31, 2025

First Submitted That Met QC Criteria

September 1, 2025

First Posted (Estimated)

September 4, 2025

Study Record Updates

Last Update Posted (Estimated)

September 4, 2025

Last Update Submitted That Met QC Criteria

September 1, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Based on a strict commitment to participant privacy protection, compliance with the terms of the ethical review protocol, and adherence to the sponsoring institution's policies, IPD from this study will not be shared at this time.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perianal Abscess

Clinical Trials on Red light exposure

Subscribe